KFF Health News’ ‘What the Health?’: 2023 is a wrap

Even without covid dominating the headlines, 2023 was a busy year for health policy.

ImmunoGen, ImmunoBiochem partner for ADCs development

ImmunoGen and ImmunoBiochem will work together to develop next-generation antibody-drug conjugates. Credit: Alpha Tauri 3D Graphics. ImmunoGen has signed a multi-target licence and option agreement

July 25, 2023

Psychedelic Assisted Therapy and Employee Benefits

The TDR Three Takeaways for Psychedelic Assisted Therapy Psychedelic Assisted Therapy is becoming accepted in some companies employee benefits, showing promise in treating complex mental

April 12, 2024

BioMarin shakes up executive team, tapping notable dealmaker James Sabry

BioMarin is bringing prominent dealmaker James Sabry onto its executive team, along with Amgen rare disease veteran Greg Friberg. Sabry will start on Oct. 7

August 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.